Sexually transmitted reinfection with a new hepatitis C genotype during pegylated interferon and ribavirin therapy [5]

AIDS

Volumn 19, Issue 6, 2005, Pages 639-640

  Den Hollander, Jan G ^a,b   Rijnders, Bart J ^b   Van Doornum, Gerard J J ^b   Van Der Ende, Marchina E ^b  

^a Medisch Centrum Rijnmond Zuid   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; LAMIVUDINE; NEVIRAPINE; PEGINTERFERON; RIBAVIRIN; VIRUS RNA; ZIDOVUDINE;

CASE REPORT; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; REINFECTION; SEXUALLY TRANSMITTED DISEASE; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS HEPATITIS;

EID: 17444375996     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000163947.24059.68     Document Type: Letter

References (3)

1. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994; 343:388-390.
2. Asselah T, Vidaud D, Doloy A, Boyer N, Martinot M, Vidaud M, et al. Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy. Gut 2003; 52:900-902.
3. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-Garcia J, Lazzarin A, et al. Peg-IFN alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004; 351:438-450.